Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 22,648 Reduced 0.17% |
$1,537,799
$67.9 p/Share
|
Apr 08
2019 |
|
MSLP
|
Wynnefield Partners Small Cap Value LP I
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,530 Added 0.56% |
$3,918
$0.6 p/Share
|
Apr 08
2019 |
|
MSLP
|
Wynnefield Partners Small Cap Value LP I
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 6,176 Added 0.84% |
$3,706
$0.6 p/Share
|
Apr 08
2019 |
|
NGM
|
Column Group L P
Director |
BUY
Open market or private purchase
|
Direct | 1,890,000 Added 99.21% |
$30,240,000
$16.0 p/Share
|
Apr 08
2019 |
|
NGM
|
Column Group L P
Director |
BUY
Conversion of derivative security
|
Direct | 13,093,134 Added 49.11% |
-
|
Apr 08
2019 |
|
GTE
|
Gmt Capital Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 100,000 Added 0.13% |
$249,000
$2.49 p/Share
|
Apr 08
2019 |
|
SILK
|
Norwest Venture Partners Xiii, LP
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 3,764 Added 0.15% |
$31,128
$8.27 p/Share
|
Apr 08
2019 |
|
SILK
|
Norwest Venture Partners Xiii, LP
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 2,458,210 Added 50.0% |
-
|
Apr 08
2019 |
|
LIN
|
Stephen F Angel
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 163,181 Reduced 41.92% |
$30,126,475
$184.62 p/Share
|
Apr 08
2019 |
|
LIN
|
Stephen F Angel
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 218,175 Added 35.92% |
$21,346,241
$97.84 p/Share
|
Apr 08
2019 |
|
LIN
|
Stephen F Angel
Director |
SELL
Open market or private sale
|
Direct | 54,994 Reduced 24.33% |
$10,144,194
$184.46 p/Share
|
Apr 08
2019 |
|
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 27,525 Reduced 0.54% |
$28,075
$1.02 p/Share
|
Apr 08
2019 |
|
BRK-A
|
Ajit Jain
Vice Chairman |
BUY
Bona fide gift
|
Indirect | 75,000 Added 27.5% |
-
|
Apr 08
2019 |
|
AMR
|
James Scott Kreutzer
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 630 Reduced 3.75% |
$38,159
$60.57 p/Share
|
Apr 08
2019 |
|
AMR
|
Charles Andrew Eidson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,292 Reduced 5.44% |
$138,735
$60.53 p/Share
|
Apr 08
2019 |
|
TPL
|
Horizon Kinetics LLC
> 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect | 0 Added 0.0% |
-
|
Apr 08
2019 |
|
TPL
|
Horizon Kinetics LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 7 Added 0.0% |
$5,702
$814.5 p/Share
|
Apr 08
2019 |
|
Y
|
William K Lavin
Director |
SELL
Open market or private sale
|
Direct | 518 Reduced 19.36% |
$318,860
$615.56 p/Share
|
Apr 08
2019 |
|
Y
|
William K Lavin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 518 Added 16.22% |
$150,308
$290.17 p/Share
|
Apr 08
2019 |
|
Y
|
Jefferson Kirby
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 528 Added 0.61% |
$112,570
$213.2 p/Share
|
Apr 08
2019 |
|
CZNC
|
Frank G Pellegrino |
BUY
Open market or private purchase
|
Direct | 295 Added 2.92% |
$7,956
$26.97 p/Share
|
Apr 08
2019 |
|
CZNC
|
Jan E Fisher
Director |
BUY
Open market or private purchase
|
Direct | 231 Added 1.16% |
$6,230
$26.97 p/Share
|
Apr 08
2019 |
|
CZNC
|
Bobbi J Kilmer |
BUY
Open market or private purchase
|
Direct | 185 Added 10.84% |
$4,989
$26.97 p/Share
|
Apr 08
2019 |
|
CHCO
|
Robert D Fisher
Director |
BUY
Open market or private purchase
|
Direct | 140 Added 0.43% |
$10,906
$77.9 p/Share
|
Apr 08
2019 |
|
CHCO
|
Tracy W Hylton Ii
Director |
BUY
Open market or private purchase
|
Direct | 130 Added 0.27% |
$10,127
$77.9 p/Share
|
Apr 08
2019 |
|
NGM
|
Merck & Co., Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,121,683 Added 24.14% |
$65,946,928
$16.0 p/Share
|
Apr 08
2019 |
|
NGM
|
Merck & Co., Inc.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 8,833,333 Added 50.0% |
-
|
Apr 08
2019 |
|
NVDA
|
Stephen C Neal
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,558 Added 50.0% |
-
|
Apr 08
2019 |
|
SNPS
|
Janice Chaffin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,503 Added 11.7% |
-
|
Apr 08
2019 |
|
SNPS
|
Bruce R Chizen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,503 Added 3.92% |
-
|
Apr 08
2019 |
|
SNPS
|
Mercedes Johnson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,503 Added 29.38% |
-
|
Apr 08
2019 |
|
SNPS
|
Chrysostomos L Nikias
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,503 Added 5.91% |
-
|
Apr 08
2019 |
|
SNPS
|
John Schwarz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,503 Added 7.34% |
-
|
Apr 08
2019 |
|
SNPS
|
Roy Vallee
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,503 Added 2.3% |
-
|
Apr 08
2019 |
|
SNPS
|
Steven Walske
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,503 Added 7.48% |
-
|
Apr 08
2019 |
|
HZNP
|
Geoffrey M. Curtis
EVP, Corporate Affairs, CCO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,101 Reduced 8.65% |
$84,223
$27.16 p/Share
|
Apr 08
2019 |
|
HZNP
|
Geoffrey M. Curtis
EVP, Corporate Affairs, CCO |
BUY
Exercise of conversion of derivative security
|
Direct | 7,000 Added 16.33% |
-
|
Apr 08
2019 |
|
MEET
|
Luxor Capital Group, LP |
BUY
Open market or private purchase
|
Indirect | 49,900 Added 0.19% |
$262,973
$5.27 p/Share
|
Apr 08
2019 |
|
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 335 Reduced 0.01% |
$16,080
$48.0 p/Share
|
Apr 08
2019 |
|
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 6,600 Reduced 0.09% |
$264,792
$40.12 p/Share
|
Apr 08
2019 |
|
MACK
|
22 Nw, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 32,873 Added 2.72% |
$190,992
$5.81 p/Share
|
Apr 08
2019 |
|
ZYXI
|
Thomas Sandgaard
President, CEO and Chairman |
SELL
Open market or private sale
|
Indirect | 78,917 Reduced 0.52% |
$376,434
$4.77 p/Share
|
Apr 08
2019 |
|
FMN
|
Bank Of America Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 526 Added 0.0% |
$7,027
$13.36 p/Share
|
Apr 05
2019 |
|
MQY
|
Bank Of America Corp |
BUY
Open market or private purchase
|
Indirect | 1,819 Added 0.0% |
$25,484
$14.01 p/Share
|
Apr 05
2019 |
|
AAP
|
Sharon Mccollam
Director |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
$0
$176.78 p/Share
|
Apr 05
2019 |
|
AAP
|
Jeffrey J Jones Ii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
$0
$176.78 p/Share
|
Apr 05
2019 |
|
MEET
|
Luxor Capital Group, LP |
BUY
Open market or private purchase
|
Indirect | 125,100 Added 0.38% |
$664,281
$5.31 p/Share
|
Apr 05
2019 |
|
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,340 Reduced 0.1% |
$208,450
$48.03 p/Share
|
Apr 05
2019 |
|
ALL
|
Glenn T Shapiro |
SELL
Payment of exercise price or tax liability
|
Direct | 4,066 Reduced 23.39% |
$390,621
$96.07 p/Share
|
Apr 05
2019 |
|
ALL
|
Glenn T Shapiro |
BUY
Exercise of conversion of derivative security
|
Direct | 9,176 Added 39.1% |
-
|
Apr 05
2019 |